Biome Australia (ASX:BIO) said it agreed on commercial terms for the distribution of its entire range in Canada on Fullscript's practitioner distribution platform, according to a Monday Australian bourse filing.
The launch of the firm's activated probiotics products on the Fullscript Canada platform is planned for February.
Its shares soared 8% in recent trading on Monday.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.